ArticleMolecular cancer therapeutics2024

Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models.

Weijie Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.